Global craniomaxillofacial device market was valued at USD1.6 billion in 2020. It is forecast to grow at a compound annual rate (CAGR of 9.0%) over the forecast period. Market growth is expected to be supported by a high preference for minimally invasive procedures due to the availability and advancements in technology. Zimmer Biomet is a leader in offering ROSA ONE Brain, a robot platform that allows for complex and minimally invasive neurosurgical procedures. The demand for craniomaxillofacial devices (CMF) is expected to rise due to the rising incidence of sports-related head and facial injuries.
A 2018 Centers for Disease Control and Prevention report estimated that between 1.7 and 3.8 million traumatic brain injury cases are reported annually in the United States. 10% of these injuries are due to recreational and sports activities. According to the U.S. Consumer Product Safety Commission, there were 454,407 head injuries related to sports that were treated in U.S. hospitals emergency rooms in 2018.
This shows the country's high growth potential for CMF device makers. CMF devices will also be in demand as a result of rising road accident incidents. Columbia University's Department of Neurology reports that motor vehicle accidents are among the leading causes of Traumatic Brain Injury (TBI) in children and adults across the U.S.
Globally, an increase in road accidents will likely boost product demand, particularly from developing countries. Due to the pandemic worldwide, some procedures have been cancelled or rescheduled, which could impact market growth.
CMF plate and screw fixing accounted for 73% of the market in 2020. This segment will continue to hold a dominant position because of the widespread use of these products in many surgical procedures such as pediatric surgery, orthognathic and tumor removal, deformity correction, and deformity correction. The fastest-growing product segment in the forecast period is Bone Graft Substitute. Bone graft substitutions are used for the reconstruction of bone defects or in cases of spine fusion.
Due to the shortage of bone graft donors, there has been a demand for bone substitutes. Calcium phosphate ceramics and calcium sulfate are some of the most popular synthetic bone substitutes. Biomatlante, a French company, offers MBCP biphasic Calcium Phosphate Synthetic BGS. It is very similar to natural bone architecture and slowly dissolves in the body. This promotes bone formation by releasing calcium and phosphate.
With a market share of more than 70% in 2020, the metallic implants segment led overall. It will continue to grow at a steady CAGR between 2021 and 2028. The high demand for metal implants is responsible for this growth. They are resistant to corrosion, provide rigid support for fractures and are less expensive than their bioabsorbable counterparts.
Because of its many advantages, titanium and its alloy are most often used in CMF surgery. These include lightweight, inert metal property, strength provided by implants, tissue acceptance and corrosion resistance. It is also used in mandibular reconstructive surgery.
The fastest-growing segment of material is expected to be bioabsorbables. This is because the use of these implants eliminates the possibility of having another surgery. The segment's growth will be driven by technological advancements in CMF surgery. These include self-enforced technology as well as the benefits associated with it (biocompatibility, reliability).
Orthognathic and dental surgery accounted for the highest revenue share at over 54% in 2020. This is due to widespread product usage to correct minor and major skeletal, and dental, deformities. The fastest-growing segment is neurosurgery & ENT. This is due to increasing rates of spinal disorders and trauma that require Cerebrospinal Fluid management (CSF). To gain more access to the brain, neurosurgeons perform craniotomies. Craniotomies can be used to treat brain trauma, infections, skull fractures and epilepsy. This segment has seen significant growth due to the widespread adoption of deep brain stimulation techniques.
Deep brain stimulation uses the implants to cover the skull following the placement of the electrode. Neurosurgical applications of cranial implant include skull and otolaryngology surgery. These devices are used to treat neuro-oncology and neurovascular diseases, spinal problems, dura mater repairs, transnasal surgery, deep brain stimulation as well as pelvic or cervical trauma. Neurosurgery is the most common use of Medpor bioabsorbable implant. Market growth is expected to be fueled by the introduction of surgical navigation technology in ENT procedures. Its adoption is expected to increase due to its many advantages, including 3D and real-time updates of virtual anatomy.
North America accounted for the largest share of the global market's revenue in 2020, accounting for more than 78%. This is due to the availability and volume of CMF procedures and technologically advanced implants. This region will continue to grow at a substantial CAGR between 2021 and 2028 because of factors such as increasing awareness about deformity correction surgery and the existence of well-established healthcare facilities.
Other than this, government initiatives such as the American Society of Craniofacial Surgery's (ASCFS) establishment to raise awareness about CMF surgery and the associated benefits are expected to increase the demand for CMF products in the region. Asia Pacific will be the fastest-growing region market over the forecast period. Regional market growth is driven by the presence of untapped potential, rapidly improving healthcare infrastructure, rapid economic development and growing patient awareness.
This market is extremely competitive and dominated only by a small number of companies. However, they have a strong presence in the U.S. market due to their extensive product offerings. These companies have adopted key strategies to expand their market share, including product launches and expansion. DePuy Synthes was a Johnson & Johnson subsidiary that launched the 3D-printed titanium facial reconstruction implants.
The major market players face stiff competition from smaller-scale medical device companies that develop more efficient products. OSSDSIGN, for example, was approved by the U.S. Food and Drug Administration in January 2017 for its OSSDSIGN Cranial Implants. Companies that are prominent in the craniomaxillofacial device market include:
DePuy Synthes, J&J
Stryker Corp.
Medtronic plc
Zimmer Biomet
Up Market Research published a new report titled “Craniomaxillofacial Devices Market research report which is segmented by Product (CMF Plate & Screw Fixation, Bone Graft Substitute), by Material (Metal, Ceramics), By Players/Companies Medtronic, DePuy Synthes (J&J), Zimmer-Biomet, Stryker”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Craniomaxillofacial Devices Market Research Report |
By Product | CMF Plate & Screw Fixation, Bone Graft Substitute |
By Material | Metal, Ceramics |
By Companies | Medtronic, DePuy Synthes (J&J), Zimmer-Biomet, Stryker |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 226 |
Number of Tables & Figures | 159 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product (CMF Plate & Screw Fixation, Bone Graft Substitute), by Material (Metal, Ceramics).
Craniomaxillofacial Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Craniomaxillofacial Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Craniomaxillofacial Devices Market Report:
Some other reports from this category!